Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

492
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
492
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
Amyloid Fibrils03:03

Amyloid Fibrils

9.6K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Dementia01:30

Dementia

115
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
115
Neural Regulation01:37

Neural Regulation

39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DEEP-GYRALNET: ENABLING MACHINE LEARNING IN GYRAL FOLDING PATTERN EXTRACTION ON CORTICAL SURFACE.

Proceedings. IEEE International Symposium on Biomedical Imaging·2026
Same author

Community-level modeling of gyral folding patterns for robust and anatomically informed individualized brain mapping.

NeuroImage·2026
Same author

AD-GPT: large language models in Alzheimer's disease.

BMC medical informatics and decision making·2026
Same author

Large language models for bioinformatics.

Quantitative biology (Beijing, China)·2026
Same author

Biophysical modeling of anatomically realistic prenatal cortical folding development.

Research square·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Related Experiment Video

Updated: Jul 8, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K

Disease2Vec: Encoding Alzheimer's progression via disease embedding tree.

Lu Zhang1, Li Wang2, Tianming Liu3

  • 1Department of Computer Science and Engineering, The University of Texas at Arlington, Arlington, TX, USA.

Pharmacological Research
|December 10, 2023
PubMed
Summary

This study introduces Disease2Vec, a novel framework for Alzheimer's Disease (AD) progression modeling. It accurately predicts patient status across continuous stages, offering a more nuanced understanding than traditional classification methods.

Keywords:
AD ProgressionDisease EmbeddingDisease Embedding Tree

More Related Videos

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

19.0K
Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
09:45

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

10.3K

Related Experiment Videos

Last Updated: Jul 8, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K
Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

19.0K
Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
09:45

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

10.3K

Area of Science:

  • Neuroscience
  • Computational Biology
  • Medical Informatics

Background:

  • Traditional Alzheimer's Disease (AD) prediction models often overlook the continuous nature of disease progression.
  • Existing methods primarily focus on binary or multi-class classification, failing to capture nuanced transitions between clinical stages.
  • Previous AD progression models primarily aimed to order biomarkers rather than predict individual patient status along a continuum.

Purpose of the Study:

  • To develop a novel learning-based embedding framework for modeling Alzheimer's Disease (AD) progression.
  • To represent the intrinsic relationships among AD clinical stages in a continuous latent space.
  • To enable accurate prediction of individual patient status across the full spectrum of AD development.

Main Methods:

  • Developed Disease2Vec, a novel learning-based embedding framework to encode relationships among AD clinical stages.
  • Generated a disease embedding tree (DETree) to represent AD progression as a continuous trajectory.
  • Utilized DETree to predict individual patient clinical status by projecting them onto the continuous trajectory.

Main Results:

  • The Disease2Vec framework and its generated DETree effectively represent AD progression.
  • The model enables efficient and accurate prediction of patient status across five fine-grained clinical groups.
  • The approach provides richer status information by analyzing patient positions within the continuous progression trajectory.

Conclusions:

  • The developed disease embedding framework (Disease2Vec) offers a significant advancement in modeling Alzheimer's Disease (AD) progression.
  • DETree provides a continuous trajectory for predicting individual patient status more accurately and with greater detail.
  • This novel approach addresses the understudied problem of predicting patient status within the spectrum of continuous AD development.